ELUT
ELUTIA INC.
NASDAQ · Healthcare · Biotechnology · US
$0.81
−3.13%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 36.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.63x
- PEG TTM
- —
- Price / book
- 2.29x
- Price / sales
- 2.97x
- Price / cash flow
- -0.82x
Enterprise value
- Enterprise value
- $26.9M
- EV / sales
- 2.22x
- EV / EBITDA
- -1.12x
- EV / EBIT
- -1.14x
- Market cap
- $36.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026